TECH

Bio Techne (TECH)

Bio Techne Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TECH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/27	21:00	PR Newswire (US)	BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE	NASDAQ:TECH	Bio Techne Corporation
2024/11/25	23:02	PR Newswire (US)	Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne	NASDAQ:TECH	Bio Techne Corporation
2024/11/20	21:00	PR Newswire (US)	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES	NASDAQ:TECH	Bio Techne Corporation
2024/11/14	21:00	PR Newswire (US)	BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO	NASDAQ:TECH	Bio Techne Corporation
2024/11/12	07:47	PR Newswire (US)	UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS	NASDAQ:TECH	Bio Techne Corporation
2024/11/11	21:00	PR Newswire (US)	BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS	NASDAQ:TECH	Bio Techne Corporation
2024/11/09	07:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TECH	Bio Techne Corporation
2024/11/08	21:00	PR Newswire (US)	BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES	NASDAQ:TECH	Bio Techne Corporation
2024/11/07	21:00	PR Newswire (US)	ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	21:00	PR Newswire (US)	BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	06:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	06:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TECH	Bio Techne Corporation
2024/11/06	06:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TECH	Bio Techne Corporation
2024/11/05	21:00	PR Newswire (US)	LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH	NASDAQ:TECH	Bio Techne Corporation
2024/10/30	19:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TECH	Bio Techne Corporation
2024/10/30	19:30	PR Newswire (US)	BIO-TECHNE DECLARES DIVIDEND	NASDAQ:TECH	Bio Techne Corporation
2024/10/30	19:30	PR Newswire (US)	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	20:00	PR Newswire (US)	ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/29	05:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TECH	Bio Techne Corporation
2024/10/22	05:11	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TECH	Bio Techne Corporation
2024/10/10	20:00	PR Newswire (US)	BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS	NASDAQ:TECH	Bio Techne Corporation